Korean J Med.
2013 Oct;85(4):439-444.
Diffuse Alveolar Hemorrhage after Adalimumab Treatment of Rheumatoid Arthritis
- Affiliations
-
- 1Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea. healthyra@schmc.ac.kr
- 2Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea.
Abstract
- Diffuse alveolar hemorrhage (DAH) is a life-threatening condition involving hemorrhage originating in the pulmonary microvasculature. The clinical syndrome is characterized by hemoptysis, hypoxemic respiratory failure, low-grade fever, and diffuse pulmonary infiltrates. The majority of cases of DAH are caused by pulmonary renal syndromes, connective tissue disorders, and drugs. Here, we present a case of DAH associated with adalimumab treatment in a patient with rheumatoid arthritis.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
- New-onset Psoriasis Induced by Adalimumab Administered for Rheumatoid Arthritis
- Adalimumab-induced Lupus Erythematosus Profundus in a Rheumatoid Arthritis Patient
- Adalimumab Induced Acute Exacerbation of Rheumatoid Arthritis Related Interstitial Lung Disease
- A Case of Diffuse Alveolar Hemorrhage Associated with Overlap syndrome
